Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABUS
BBNX
Add up to 3 more stocks
ABUS
Arbutus Biopharma Corp
-4.18%
$4.47-0.20Delayed quote: Oct 6, 2026, 1:15 PM EDT
Market Cap
$883.98M
52W Range
$3.50 - $5.45
BBNX
Beta Bionics, Inc.
-2.51%
$18.48-0.47Delayed quote: Oct 6, 2026, 1:15 PM EDT
Market Cap
$831.18M
52W Range
$8.80 - $32.71
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 5.73 | N/A |
| Forward P/E | 6.05 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.42 | 3.24 |
| P/S Ratio | 4.86 | 6.98 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | 5.90 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 58.3% |
| Operating Margin | -192.1% | -69.8% |
| Net Margin | 84.2% | -61.3% |
| ROE | 59.2% | -28.5% |
| ROA | 55.9% | -25.0% |
| ROIC | 54.4% | -31.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 81.42 | 8.88 |
| Quick Ratio | 81.42 | 7.96 |
| Debt/Equity | 0.01 | 0.03 |
| Interest Coverage | -278.88 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.